Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXSLEEP: Nocturnal Dexmedetomidine and Postoperative Sleep in Elderly Thoracoscopic Surgery
2023-510403-22-00Phase 4Authorised
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Postoperative sleep disturbance (PSD), postoperative pain and postoperative delirium (POD) comparing Nocturnal Dexdor with Placebo (sodium chloride 0.9%) (2 arms). Primary endpoint: Early quality of recovery (QoR-15) on postoperative day 1. Planned start Apr 2024; status: authorised.
02
Drugs
dexmedetomidine
03
Conditions
Postoperative sleep disturbance (PSD)postoperative painpostoperative delirium (POD)
Beyond the preview
Go deeper on 2023-510403-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510403-22-00.